Nucleosomes and neutrophil activation in sickle cell disease painful crisis

Activated polymorphonuclear neutrophils play an important role in the pathogenesis of vaso-occlusive painful sickle cell crisis. Upon activation, polymorphonuclear neutrophils can form neutrophil extracellular traps. Neutrophil extracellular traps consist of a meshwork of extracellular DNA, nucleosomes, histones and neutrophil proteases. Neutrophil extracellular traps have been demonstrated to be toxic to endothelial and parenchymal cells. This prospective cohort study was conducted to determine neutrophil extracellular trap formation in sickle cell patients during steady state and painful crisis. As a measure of neutrophil extracellular traps, plasma nucleosomes levels were determined and polymorphonuclear neutrophil activation was assessed measuring plasma levels of elastase-α1-antitrypsin complexes in 74 patients in steady state, 70 patients during painful crisis, and 24 race-matched controls using Enzyme Linked Immunosorbent Assay. Nucleosome levels in steady state sickle cell patients were significantly higher than levels in controls. During painful crisis levels of both nucleosomes and elastase-α1-antitrypsin complexes increased significantly. Levels of nucleosomes correlated significantly to elastase-α1-antitrypsin complex levels during painful crisis, (Sr = 0.654, P<0.001). This was seen in both HbSS/HbSβ0-thalassemia (Sr=0.55, P<0.001) and HbSC/HbSβ+-thalassemia patients (Sr=0.90, P<0.001) during painful crisis. Levels of nucleosomes showed a correlation with length of hospital stay and were highest in patients with acute chest syndrome. These data support the concept that neutrophil extracellular trap formation and neutrophil activation may play a role in the pathogenesis of painful sickle cell crisis and acute chest syndrome.

[1]  C. Esmon,et al.  Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C , 2012, Critical care medicine.

[2]  S. Middeldorp,et al.  Circulating Nucleosomes and Neutrophil Activation as Risk Factors for Deep Vein Thrombosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[3]  C. Scheiermann,et al.  Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice. , 2012, Blood.

[4]  B. Lämmle,et al.  Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. , 2012, Blood.

[5]  Yue Jin,et al.  Circulating nucleosomes as a predictor of sepsis and organ dysfunction in critically ill patients. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[6]  A. Walch,et al.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo , 2012, The Journal of experimental medicine.

[7]  K. Preissner,et al.  Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones , 2012, PloS one.

[8]  C. Silliman,et al.  A two‐event In vitro model of acute chest syndrome: The role of secretory phospholipase A2 and neutrophils , 2011, Pediatric blood & cancer.

[9]  B. Biemond,et al.  Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management , 2011, American journal of hematology.

[10]  T. Ushiki,et al.  Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis , 2011, Pathology international.

[11]  A. Mantovani,et al.  Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis. , 2011, Blood cells, molecules & diseases.

[12]  J. Hartwig,et al.  Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.

[13]  K. Preissner,et al.  Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases , 2010, Nature Medicine.

[14]  P. Erne,et al.  Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis‐mediated cell death , 2010, FEBS letters.

[15]  Jun Xu,et al.  Extracellular histones are major mediators of death in sepsis , 2009, Nature Medicine.

[16]  P. Frenette,et al.  HETEROTYPIC INTERACTIONS ENABLED BY POLARIZED NEUTROPHIL MICRODOMAINS MEDIATE THROMBO-INFLAMMATORY INJURY , 2009, Nature Medicine.

[17]  L. Aarden,et al.  Nucleosome‐releasing factor: a new role for factor VII‐activating protease (FSAP) , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  M. Gladwin,et al.  Pulmonary complications of sickle cell disease. , 2008, The New England journal of medicine.

[19]  K. Ataga,et al.  Fibronectin bridges monocytes and reticulocytes via integrin α4β1 , 2008, British journal of haematology.

[20]  M. Telen.  Faculty Opinions recommendation of Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1. , 2008 .

[21]  P. Frenette,et al.  Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion. , 2007, Blood.

[22]  S. Thein,et al.  Circulating DNA: a potential marker of sickle cell crisis , 2007, British journal of haematology.

[23]  Volker Brinkmann,et al.  Beneficial suicide: why neutrophils die to make NETs , 2007, Nature Reviews Microbiology.

[24]  C. Garlanda,et al.  The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps , 2007, The Journal of experimental medicine.

[25]  Christine Laine,et al.  In the Clinic , 2007, Annals of Internal Medicine.

[26]  S. Ofori-Acquah,et al.  Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells. , 2006, American journal of physiology. Heart and circulatory physiology.

[27]  S. Simon,et al.  Inflammatory potential of neutrophils detected in sickle cell disease , 2004, American journal of hematology.

[28]  B. Coller,et al.  Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes. , 2004, Blood.

[29]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[30]  B. Lämmle,et al.  Elevated nucleosome levels in systemic inflammation and sepsis* , 2003, Critical care medicine.

[31]  A. van Nieuwenhuijze,et al.  Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus , 2003, Annals of the rheumatic diseases.

[32]  J. Goldman,et al.  Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells , 2002, European journal of haematology.

[33]  L. Chan,et al.  Outcome in hemoglobin SC disease: A four‐decade observational study of clinical, hematologic, and genetic factors , 2002, American journal of hematology.

[34]  B. Coller,et al.  Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  V. Torri,et al.  Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients , 2001, Critical care medicine.

[36]  J. Elion,et al.  Acute clinical events in 299 homozygous sickle cell patients living in France , 2000, European journal of haematology.

[37]  A. Duits,et al.  Neutrophil activation in sickle cell disease , 1999, Journal of leukocyte biology.

[38]  J. Piette,et al.  The key role of nucleosomes in lupus. , 1999, Arthritis and rheumatism.

[39]  I. Okpala,et al.  Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA) , 1998, European journal of haematology.

[40]  M L Terrin,et al.  Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent , 1996, Medicine.

[41]  P. Lane.  Sickle cell disease. , 1996, Pediatric clinics of North America.

[42]  H. Meiselman,et al.  Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst. , 1996, Blood.

[43]  G. Rodgers,et al.  Mortality in sickle cell disease. , 1994 .

[44]  O. Castro,et al.  The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. , 1994, Blood.

[45]  G. Serjeant,et al.  The painful crisis of homozygous sickle cell disease: clinical features , 1994, British journal of haematology.

[46]  O. Platt,et al.  Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.

[47]  R. Colman,et al.  Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. , 1992, The Journal of laboratory and clinical medicine.

[48]  E Vichinsky,et al.  Pain in sickle cell disease. Rates and risk factors. , 1991, The New England journal of medicine.

[49]  Graham R Serjeant,et al.  Sickle-cell disease , 1984, The Lancet.

[50]  S. Ballas,et al.  Clinical, hematological, and biochemical features of Hb SC disease , 1982, American journal of hematology.

[51]  E. Lima,et al.  Oxidative stress in sickle cell disease , 2013, Revista brasileira de hematologia e hemoterapia.

[52]  T. Pearson,et al.  Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. , 1998, Blood.

[53]  Scott T. Miller,et al.  Cerebrovascular accidents in sickle cell disease: rates and risk factors. , 1998, Blood.